An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin

Author: Goel R.   Chouinard E.   Stewart D. J.   Huan S.   Hirte H.   Stafford S.   Waterfield B.   Roach J.   Lathia C.   Agarwal V.   Humphrey R.   Walsh W.   Matthews S.   Seymour L.  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.23, Iss.1, 2005-01, pp. : 63-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content